article thumbnail

Engineering T cells to attack cancer broadly

Scienmag

Through T cell engineering, researchers at Virginia Commonwealth University Massey Cancer Center show that it’s possible to arrest tumor growth for a variety of cancers and […]. A new approach to immunotherapy arrests solid tumor growth for a variety of cancers and squashes the spread of cancer to other tissues, in mice.

article thumbnail

GentiBio launches to develop engineered regulatory T cells for autoimmune and inflammatory diseases

Scienmag

Announces exclusive licensing partnerships for proprietary regulatory T cell engineering technologies with Seattle Children’s Research Institute, Benaroya Research Institute and MIGAL Galilee Research Institute Credit: GentiBio, Inc. BOSTON, Mass., SEATTLE, Wash., and QIRYAT SHMONA, Israel, August 5, 2020 – GentiBio, Inc.,

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How Voyage Food Reverse-Engineered Popular Foods + Boochcraft Hard Kombucha – Xtalks Food Podcast Ep. 61

XTalks

Voyage Foods, a California-based startup that has reverse-engineered chocolate, peanut butter and coffee, recently closed a $36 million Series A investment round. She discusses the problematic sourcing and production challenges associated with chocolate and coffee, as well as the millions of Americans that have peanut allergies.

article thumbnail

Providing the Blueprint for Gen AI Adoption in Clinical Trials

ACRP blog

AI’s margin gains simply aren’t as big an incentive for life sciences businesses to embark on multi-year data engineering projects. We’re also insulated from issues like labor shortages that have driven other industries to seek AI efficiency gains. Yet, the opportunity extends beyond simply increasing profitability.

article thumbnail

Molecule holds promise to reprogram white blood cells for better cancer treatment

Scienmag

In this type of therapy, T cells, a type of white blood cell, are collected from a patient’s blood and subjected to genetic engineering to produce T cells carrying a synthetic molecule termed chimeric antigen receptor (CAR) […].

article thumbnail

Genetically engineered T cells could lead to therapies for autoimmune diseases

Scienmag

A new study has found that a novel T cell genetically engineered by University of Arizona Health Sciences researchers is able to target and attack pathogenic T cells that cause Type 1 diabetes, which could lead to new immunotherapy treatments.

article thumbnail

New serological assay provides rapid, accurate testing for SARS-CoV-2 antibodies

Scienmag

Rebecca DuBois, associate professor of biomolecular engineering at UC Santa […].